COVID-19
Lancet: Early COVID-19 Symptoms Differ Among Age Groups and Genders
Age and gender matter when it comes to the early COVID-19 symptoms, according to new research from Lancet Digital Health. The differences are most notable between younger age groups (16-to-59 years) compared to older age groups (60-to-80 years and older). Also, men have different symptoms compared to women in theRead
DISCOVERY: Researchers Find Phospholipase A2 group IIA Enzyme Drives COVID-19 Mortality
University of Arizona researchers found what may be the key molecular mechanism responsible for COVID-19 mortality, it is the phospholipase A2 group IIA, or sPLA2-IIA enzyme. The sPLA2-IIA enzyme is known to be responsible for severe inflammation, researchers now believe it could be a key mechanism driving COVID-19 severity andRead
CDC Changes Indoor Mask Recommendations
As a result of the rising rates of infection from the Delta-variant of the COVID-19 virus, the Centers for Disease Control reversed indoor mask recommendations under the following conditions: Fully vaccinated people should wear a mask in public indoor settings in areas of substantial or high transmission. See this searchableRead
Lancet: Half of Hospitalized COVID-19 Patients Develop One-Or-More Complications
A study in The Lancet shows that one-in-two hospitalized COVID-19 patients develop one-or-more complications. They include renal, complex respiratory, and systemic complications, as well as cardiovascular, neurological, and gastrointestinal and liver complications. Overall, complications occurred in 50% of all participants, including in 44% (21,784 of 50,105) of participants who survived.Read
Math Model Shows Combo-drugs Cepharanthine and Nelfinavir as Possible Treatment for COVID-19
Although vaccines are still being administered across the globe for COVID-19, the administration of the shots is not uniform across all countries. Even so, there are still so many unanswered questions for treatment and prevention of the virus. Will the recent vaccines work for variants as they arise? Will theRead
DISCOVERY: New Study Points to the Mouth and Gums as a Transmission Path for COVID-19
Are the Mouth and Gums a Transmission Path for COVID-19? Could Good Oral Health and Mouthwash Reduce Risk? Just released research, published in Genesis Publications, introduces a new model explaining why gum disease and poor oral hygiene could be a more accurate predictor for COVID-19 severity than patient age,ethnicity, orRead
Long-Term Cardiovascular and Heart Complications of COVID-19 in Younger Adults
Young healthy adults with mild COVID-19 symptoms may have an increased risk of cardiovascular and heart complications, and may continue for some time after infection. This according to new research published in Experimental Physiology, highlights the possible long term health impacts of COVID-19 non-hospitalized young adults who had only minorRead
Major Boost in COVID-19 Protective Antibodies Seen in Breast Milk after Vaccination
Nursing mothers who receive a COVID-19 vaccine may pass protective antibodies to their babies through breast milk for at least 80 days following vaccination, suggests new research from Washington University School of Medicine in St. Louis. “Our study showed a huge boost in antibodies against the COVID-19 virus in breastRead
Web Based Platform: 14 Different Diseases with Common Metabolic Pathways
In medicine, the terms like remarkable and ground breaking seldom occur. However researchers from Cambridge University and the Institute of Computational Biology, Munich, Germany have done something beneficially remarkable by identifying 14 different diseases with common metabolic pathways and placing the information on an open access webserver. As is wellRead
Lab Study: High-fiber Short Chain Fatty Acids May Control COVID-19 Related Gut Tissue Inflammation
A study conducted at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, shows that compounds produced by gut microbiota (bacteria and other microorganisms) during fermentation of insoluble fiber from dietary plant matter do not affect the ability of the novel coronavirus SARS-CoV-2 to enter and replicateRead
